Inflammatory bowel disease, a dysregulated host-microbiota interaction: Are probiotics a new therapeutic option?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 12, 2008, Pages 1777-1779

  Howarth, Gordon S ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VSL3;

BACTERIAL STRAIN; BIFIDOBACTERIACEAE; EDITORIAL; ENTERITIS; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; MUCOSAL IMMUNITY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 57049144187     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05685.x     Document Type: Editorial

References (16)

1. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007 117 : 514 21.
2. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008 134 : 577 94.
3. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J. Gastroenterol. 2008 14 : 165 73.
4. Feller M, Huwiler K, Stephan R et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 2007 7 : 607 13.
5. Rubin DT, Kornblunth A. Role of antibiotics in the management of inflammatory bowel disease: a review. Rev. Gastroenterol. Disord. 2005 5 (Suppl. 3 S10 5.
6. O'Hara AM, Shanahan F. Mechanisms of action of probiotics in intestinal diseases. Sci. World J. 2007 7 : 31 46.
7. Nanda Kumar NS, Balamurugan R, Jayakanthan K, Pulimood A, Pugazhendhi S, Ramakrishna BSJ. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulphate. J. Gastroenterol. Hepatol. 2008 23 : 1834 9.
8. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis. Colon Rectum 2007 50 : 2075 82.
9. Bibiloni R, Fedorak RN, Tannock GW et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 2005 100 : 1539 46.
10. Tsuda Y, Yoshimatsu Y, Aoki H et al. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy. Scand. J. Gastroenterol. 2007 42 : 1306 11.
11. Geier MS, Butler RN, Giffard PM, Howarth GS. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int. J. Food Microbiol. 2007 114 : 267 74.
12. Torok VA, Ophel-Keller K, Loo M, Hughes RJ. Application of methods for identifying broiler chicken gut bacterial species linked with increased energy metabolism. Appl. Environ. Microbiol. 2008 74 : 783 91.
13. Kamil R, Geier MS, Butler RN, Howarth GS. Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy. Dig. Dis. Sci. 2007 52 : 1247 52.
14. Guarner F. Prebiotics in inflammatory bowel diseases. Br. J. Nutr. 2007 98 (Suppl. 1 S85 9.
15. Geier MS, Butler RN, Giffard PM, Howarth GS. Prebiotic and synbiotic fructooligosaccharide administration fails to reduce the severity of experimental colitis in rats. Dis Colon Rectum 2007 50 : 1061 9.
16. Rachmilewitz D, Karmeli F, Takabayashi K et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002 122 : 1428 41.